openPR Logo
Press release

Axillary Hyperhidrosis Treatment Market 2032: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight

08-04-2025 07:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Axillary Hyperhidrosis Treatment Market

Axillary Hyperhidrosis Treatment Market

Alopecia Areata Companies are Eli Lilly and Company/Incyte Corporation, Pfizer, Legacy Healthcare, Pfizer, Q32 Bio Inc., AbbVie, Amgen, Concert Pharmaceuticals, Bristol-Myers Squibb, Reistone Biopharma, Inmagene LLC, Suzhou Zelgen Biopharma, Nektar Therapeutics, AnaptysBio, Inc., LEO Pharma, Eli Lilly and Company, and others.
(Albany, USA) DelveInsight's "Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The Axillary Hyperhidrosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Axillary Hyperhidrosis market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Axillary Hyperhidrosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Axillary Hyperhidrosis market.

To Know in detail about the Axillary Hyperhidrosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axillary Hyperhidrosis Market Forecast [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Some of the key facts of the Axillary Hyperhidrosis Market Report:

* The Axillary Hyperhidrosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* In February 2025, Dermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin conditions, announced that the Australian Patent Office has accepted its patent application for the DMT410 program targeting hyperhidrosis. The patent, titled "Compositions for the Treatment of Skin Conditions" (Australian Patent Application No. 2109284621), further enhances Dermata's global intellectual property portfolio for DMT410. Unless opposed by a third party, the patent will be officially granted three months after acceptance.
* In June 2024, Botanix Pharmaceuticals announced that it has received approval from the US Food and Drug Administration (FDA) for Sofdra (sofpironium) gel, 12.45%, for the treatment of excessive underarm sweating (primary axillary hyperhidrosis). The treatment is approved for use in adults and children aged nine years and older. Sofdra is the first and only new chemical entity to be approved in the US for this condition.
* In January 2024, InMode MD Ltd. offers the InMode Pro System with the Morpheus8 Applicator, a computerized device that produces radio frequency energy utilizing Fractional RF technology. The Morpheus8 Applicator, equipped with a 24-pin tip, is specifically designed for treating primary hyperhidrosis in the underarm area.
* In 2022, the Axillary Hyperhidrosis market in the US recorded the highest size, reaching around USD 500 million, and is projected to grow further by 2032.
* In the US, the estimated prevalence of Axillary Hyperhidrosis is 2.8%, affecting approximately 7.8 million individuals. Among them, 50.8% (around 4.0 million people or 1.4% of the US population) reported experiencing axillary hyperhidrosis.
* There are currently too few and insufficient epidemiologic data on hyperhidrosis to establish accurate prevalence or impact estimates. According to DelveInsight analysts, there were 10,491,560 cases of axillary hyperhidrosis (AH) in the US as a whole
* Based on the HDSS scale, the degree of axillary hyperhidrosis was assessed. According to DelveInsight, 1,584,618 people had non-severe symptoms and roughly 1,716,670 people had severe symptoms in 2021
* In the US, there were 3,301,288 diagnosed cases of axillary hyperhidrosis (AH) overall in 2021.
* The prevalence of primary axillary hyperhidrosis in the population of Japan aged 5-64 years is 5.75% (males, 6.60%; females, 4.72%), according to a study by Murota et al. (2021).
* Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Person & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
* Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipesl, and others
* The Axillary Hyperhidrosis epidemiology based on gender analyzed that in the US, out of the total diagnosed cases of Axillary Hyperhidrosis in 2021, 93% accounted for primary hyperhidrosis and 7% accounted for secondary hyperhidrosis
* The Axillary Hyperhidrosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Axillary Hyperhidrosis pipeline products will significantly revolutionize the Axillary Hyperhidrosis market dynamics.

Axillary Hyperhidrosis Overview

Axillary hyperhidrosis is a medical condition characterized by excessive sweating in the underarm (axillary) area. This condition goes beyond the normal sweating that helps regulate body temperature and can be persistent and unpredictable. People with axillary hyperhidrosis often experience significant discomfort and embarrassment due to the constant wetness, which can interfere with daily activities, social interactions, and overall quality of life.

Get a Free sample for the Axillary Hyperhidrosis Market Report: https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market [https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Axillary Hyperhidrosis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Axillary Hyperhidrosis Epidemiology Segmentation:

The Axillary Hyperhidrosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

* Total Prevalence of Axillary Hyperhidrosis
* Prevalent Cases of Axillary Hyperhidrosis by severity
* Gender-specific Prevalence of Axillary Hyperhidrosis
* Diagnosed Cases of Episodic and Chronic Axillary Hyperhidrosis

Download the report to understand which factors are driving Axillary Hyperhidrosis epidemiology trends @ Axillary Hyperhidrosis Epidemiology Forecast [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Axillary Hyperhidrosis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Axillary Hyperhidrosis market or expected to get launched during the study period. The analysis covers Axillary Hyperhidrosis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Axillary Hyperhidrosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Axillary Hyperhidrosis Therapies and Key Companies

* Sofpironium bromide (BBI-4000): Botanix Pharma
* VASER: Sound Surgical Technologies, LLC.
* Glycopyrronium Bromide: Dr. August Wolff GmbH
* Meditoxin: Medy-Tox
* glycopyrronium Topical Wipes: Journey Medical Corporation

Discover more about therapies set to grab major Axillary Hyperhidrosis market share @ Axillary Hyperhidrosis Treatment Market [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Scope of the Axillary Hyperhidrosis Market Report

* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Axillary Hyperhidrosis Companies: Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corporation, Person & Covey, Stratus Pharmaceuticals, Journey Medical Corporation, Allergan, AbbVie, Brickell Biotech, Dermavant Sciences, Dermata Therapeutics, Viatris, Candesant Biomedical, and others
* Key Axillary Hyperhidrosis Therapies: Sofpironium Bromide, VASE, Glycopyrronium Bromide, Meditoxin, glycopyrronium Topical Wipes, and others
* Axillary Hyperhidrosis Therapeutic Assessment: Axillary Hyperhidrosis current marketed and Axillary Hyperhidrosis emerging therapies
* Axillary Hyperhidrosis Market Dynamics: Axillary Hyperhidrosis market drivers and Axillary Hyperhidrosis market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Axillary Hyperhidrosis Unmet Needs, KOL's views, Analyst's views, Axillary Hyperhidrosis Market Access and Reimbursement

To know more about Axillary Hyperhidrosis companies working in the treatment market, visit @ Axillary Hyperhidrosis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-ahh-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Table of Contents

1. Axillary Hyperhidrosis Market Report Introduction

2. Executive Summary for Axillary Hyperhidrosis

3. SWOT analysis of Axillary Hyperhidrosis

4. Axillary Hyperhidrosis Patient Share (%) Overview at a Glance

5. Axillary Hyperhidrosis Market Overview at a Glance

6. Axillary Hyperhidrosis Disease Background and Overview

7. Axillary Hyperhidrosis Epidemiology and Patient Population

8. Country-Specific Patient Population of Axillary Hyperhidrosis

9. Axillary Hyperhidrosis Current Treatment and Medical Practices

10. Axillary Hyperhidrosis Unmet Needs

11. Axillary Hyperhidrosis Emerging Therapies

12. Axillary Hyperhidrosis Market Outlook

13. Country-Wise Axillary Hyperhidrosis Market Analysis (2019-2032)

14. Axillary Hyperhidrosis Market Access and Reimbursement of Therapies

15. Axillary Hyperhidrosis Market Drivers

16. Axillary Hyperhidrosis Market Barriers

17. Axillary Hyperhidrosis Appendix

18. Axillary Hyperhidrosis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=axillary-hyperhidrosis-treatment-market-2032-ema-pdma-fda-approval-clinical-trials-medication-prevalence-revenue-statistics-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Axillary Hyperhidrosis Treatment Market 2032: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight here

News-ID: 4132277 • Views:

More Releases from ABNewswire

Severe Atopic Dermatitis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight
Severe Atopic Dermatitis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinica …
Severe Atopic Dermatitis Companies are Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, Pfizer, and others. (Albany, USA) DelveInsight's "Severe Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Severe
Professional Services Automation by IBN Technologies Enhances Workflow Precision in U.S. Healthcare Systems
Professional Services Automation by IBN Technologies Enhances Workflow Precision …
U.S. hospitals are transforming finance operations by shifting to professional services automation. With AI and automation, providers improve claims accuracy, reduce manual work, and gain visibility into complex financial cycles. Digital experts like IBN Technologies deliver tailored solutions that help hospitals run smarter, scale faster, and maintain compliance. Miami, Florida, 04 Aug 2025 Healthcare providers in the U.S. are advancing operational strategies that prioritize both care quality and administrative accuracy. Financial
USA Healthcare Providers Adopt Professional Services Automation with IBN Technologies for Operational Gains
USA Healthcare Providers Adopt Professional Services Automation with IBN Technol …
This news highlights the growing adoption of professional services automation within the U.S. healthcare industry. Readers will learn how healthcare providers are improving billing accuracy, accelerating revenue cycles, and reducing administrative burdens. The integration of AI and automation tools is driving scalable, compliant financial operations. Insights reveal how expert solutions are shaping future-ready healthcare workflows and decision-making. Miami, Florida, 04 Aug 2025 Healthcare providers in the U.S. are actively adopting streamlined
Smart Pumps Market to Reach USD 1.24 Billion by 2030, Driven by Increasing Demand from Oil & Gas and Water Treatment Industries - Mordor Intelligence
Smart Pumps Market to Reach USD 1.24 Billion by 2030, Driven by Increasing Deman …
Mordor Intelligence has published a new report on the Smart Pumps Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction According to a 2025 report on the smart pumps market by Mordor Intelligence,the market size is projected to grow from USD 0.86 billion in 2025 to USD 1.24 billion by 2030, at a CAGR of 7.59% during the forecast period. This growth is supported by the rising

All 5 Releases


More Releases for Axillary

Axillary Crutches Market Size 2024 to 2031.
Market Overview and Report Coverage Axillary crutches are commonly used mobility aids to assist individuals in walking when they have difficulty bearing weight on their legs or feet. These crutches are designed with padded axillary supports that rest under the arms and provide support while walking. The Axillary Crutches Market is expected to witness significant growth in the coming years, with a projected CAGR of 12.20% during the forecasted
Massive Growth in Axillary Crutches Market, 2021-2026
(Portland, United States): Big Market Research newly added a research report on the Axillary Crutches Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in
Axillary Crutches Market - Size, Share, Outlook, and Opportunity
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be
Axillary Crutches Market - Size, Share, Outlook, and Opportunity Analysis, 2018 …
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be
Global Axillary Crutches Market: Top Players - Invacare, Stander, Sizewise
​Latest industry research report on: Global Axillary Crutches Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @​https://www.marketresearchreports.biz/sample/sample/1001065 This report studies sales (consumption) of ​Axillary Crutches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Millennial Medical Ergoactives Cardinal Health AMG Medical Inc/Airgo Carex Graham Field Nova
Global Axillary Crutches Market Research Report 2017
Report Hive Market Research Released a New Research Report of 102 pages on Title " Global Axillary Crutches Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Axillary Crutches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented